Neuropathy
Scientists at University of Kentucky describe research in neuropathy
Published in Cardiovascular Device Liability Week, February 7th, 2010
"Therefore, we determined the analgesic efficacy of ranolazine in a preclinical animal model of neuropathic pain. Both intraperitoneal and oral administration of ranolazine dose-dependently inhibited the mechanical and cold allodynia associated with spared nerve injury, without producing ataxia or other behavioral side effects," wrote H.J. Gould and colleagues, University of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Heart Failure Quality of Care
Reports from Duke University, Center for Clinical and Genetic Economics advance knowledge in heart failure quality of care - INC Research, Inc.
INC Research Bolsters Regulatory Affairs Team for Europe and Asia - RadarFind Corporation
RadarFind Introduces Sentry AV for RTLS Alarm - St. Jude Medical, Inc.
St. Jude Medical Achieves Recognition for Security of Patient Data and Completes Successful Testing to Streamline Connection to Patient Medical Records - Abdominal Aortic Aneurysm
Data on abdominal aortic aneurysm detailed by M.A.M. Peirano and co-authors - Abdominal Aortic Aneurysm
New abdominal aortic aneurysm research from General Hospital, Department of Cardiovascular Surgery discussed - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
